Align Tech, Inc. v. Federal Ins. Co., ___ F. Supp. 2d ___, 2009 WL 4282098 (N.D. Cal. 2009)
The court denied the insurer’s motion to dismiss and granted instead plaintiff’s motion for partial summary judgment re the duty to defend as well as for defendant Federal’s concurrent motion for summary judgment.
At issue were two insurance policies, a premises/operations liability policy and a commercial access and umbrella policy issued by Federal to Align. The pertinent coverage was for personal injury and defined as personal injury “includes injury . . . caused by an offense of: D. electronic, oral, written or other publication of material that: 1. libels or slanders or person or organization (which does not include disparagement of goods, products, property or services); …” Id. at *2.
Also of interest was an intellectual property laws and rights exclusion applicable to both policies. The underlying lawsuit in San Francisco Superior Court entitled Align Technology, Inc. v. Ortho Clear, Inc., et al., No. CGC-05-438361 asserted 15 causes of action including unfair competition in violation of CBC § 17200 misappropriation of trade secrets, breach of contract, common law and fair competition, intentional interference with economic advantage, conversion, unjust enrichment and civil conspiracy.
Allegedly, former Align employees attempted to “unlawfully utilize Align’s intellectual property, confidential information and employees to start a competing dental device company.” Litigation was one including five lawsuits in total and one ITC action. The cross-complaint against Align asserted 17 causes of action including unfair competition in violation of Cal. Bus. & Prof. Code § 17200, common law and fair competition, intentional interference with respect to economic advantage, defamation (libel), defamation (slander) and breach of contract.
Align allegedly “embarked on a deliberate strategy to destroy OrthoClear … before its first sale was ever undertaken. This strategy manifested itself in a pattern of misconduct, of which the Align lawsuit itself is but a small part. Align’s misconduct encompasses threatening employees that they would be sued personally and destroyed financially if they joined OrthoClear, holding a press conference in which Align defamed the founding members of OrthoClear, instituting the present lawsuit to preclude competition slow [sic] an emerging company from entering the marketplace, and interfering with potential investors interested in OrthoClear.” Id. at *3.
The libel and slander counts arose from communications to other Align employees and the general public who were the recipient of defamatory statements. A number of communications were referenced. These included a series of questions implying that
“(a) OrthoClear's product was ‘merely a copycat’ that infringed on Align's patents, (b) OrthoClear could not possibly compete lawfully with Align and that its founders had violated noncompetition and nonsolicitation agreements, (c) OrthoClear's sources of funding were suspect, and (d) OrthoClear's stock options granted to its employees would not be valuable.”
Id. at *3.
In addition,
On or around February 5, 2005, Align issued a memorandum to its non-management employees which “grossly misrepresented the value of the stock options OrthoClear had promised .... [and] implied that OrthoClear would never go public, would not survive litigation with Align, and would never become profitable.” Id. ¶ 53. The memorandum “specifically maligned Chishti's track record during his tenure at Align.”
Id. at *4.
Settlement of the matter thereafter arose including a one-time payment of $20 million from Align to OrthoClear. Following a February 17, 2005 tender a March 10, 2005 denial was issued.
The court relied on the intellectual property laws or rights exclusion to bar a defense. Bad faith allegations were asserted because Federal was fully aware that none of the exclusions decided came even remotely close to eliminating potential for coverage which is clearly evident on the face of OrthoClear’s cross-complaint.
Align asked the court to follow KLA-Tencor Corp. v. Travelers Indemnity Company of Illinois, 2003 WL 21655097 (N.D. Cal. Apr. 11, 2003) rather than Molecular Bioproducts, Inc. v. St. Paul Mercury Ins. Co., 2003 WL 23198852 (S.D. Cal. July 9, 2003). Id. at *9.
The court found neither Molecular Bioproducts or KLA-Tencor controlling. It noted that the present IP exclusion was neither as narrow as that in KLA-Tencor nor as broad as that in Molecular Bioproducts. It noted that unlike the facts in Molecular Bioproducts a singular intellectual property claim does not automatically disqualify the entire suit for coverage.
Following applicable rules of California Insurance Coverage Law, which required them to be interpreted based on the ordinary understanding of a lay person and exclusionary clauses be interpreted narrowly and requirement that they be “conspicuous, plain and clear,” Federal’s language did not put an insured reasonably on notice that Federal will not cover claims in a lawsuit whenever that lawsuit also includes a claim for intellectual property. Id. at *9.
Looking at the history of California’s interpretation of the term “unfair competition” the court concluded:
The only reasonable interpretation of the phrase in context is that it refers to statutory law to the extent it concerns piracy, common law unfair competition, and similar practices. Thus, some claims under § 17200 may trigger the exclusions, but the determination must be made based on the factual allegations. See CNA Cas., 176 Cal.App.3d at 606 07.
Id. at *11.
The court rejected Federal’s argument that regardless of whether the alleged defamatory statements referred specifically to intellectual property rights all arose out of the Align’s dispute with OrthoClear since it was, at heart, a dispute over intellectual property and all of Align’s statements were made in an attempt to protect its intellectual property from OrthoClear.
Accepting Federal's argument would allow it to cobble together the most favorable allegations from both parties and disregard the rest. Such an approach defies the public policy of strictly construing exclusionary clauses. At best, the conflicting allegations might create a factual issue as to whether injury from each statement was related to an alleged intellectual property dispute. Since a factual dispute does not completely eliminate the possibility of coverage, it does not relieve Federal of its duty to defend. Mirpad, LLC v. California Ins. Guar. Ass'n, 132 Cal.App. 4th 1058, 1068 (2005) (“If coverage depends on an unresolved dispute over a factual question, the very existence of that dispute would establish a possibility of coverage and thus a duty to defend.”).
Id. at *12.
The court concluded:
The Cross-Complaint alleged that, in addition to accusing it of violating intellectual property laws, Align was liable for defamation because, among other things, it accused OrthoClear of making false promises to prospective employees, insinuated that former Align executives breached non-competition agreements, maligned Chishti's management of Align, and accused OrthoClear of recruiting its entire sales force and unlawfully soliciting its employees. On their face, such alleged statements bear no relation to the assertion of intellectual property rights. Nor did OrthoClear allege that these were part of any intellectual property dispute. Rather, OrthoClear alleged that Align was engaged in “a deliberate strategy to destroy OrthoClear ... of which the Align lawsuit itself is but a small part.”
Id. at *12.
The court found that the settlement was covered so long as it was reasonable since a wrongful denial of a defense entitled the insured to make such a settlement which could be used as presumptive evidence in the insured’s liability on the underlying claim, including the amount of such liability. Citing Isaacson v. California Ins. Guar. Assoc., 44 Cal. 3d 775, 791 (1988). Id. at *13.
Some portions of the settlement may be covered. It also delayed resolution of that issue to a later adjudication. The court concluded that Federal’s reading is a result out of an exclusion for “intellectual property laws or rights” was in bad faith, particularly if Align is able to prove its other allegations, finding the genuine issue rule did not preclude any possible bad faith action as a matter of law.